LangChain Healthcare RAG Evaluation: A Singapore Hospital Tutorial

LangChain Healthcare RAG Evaluation: A Singapore Hospital Tutorial

When a Singapore hospital deploys a retrieval-augmented generation (RAG) system to answer clinical queries—whether for discharge summaries, medication reconciliation, or clinical decision support—the question isn't whether the LLM sounds fluent. It's whether the system retrieves the right evidence, reasons correctly, and fails safely when it should defer to a human. We've seen production RAG systems pass fluency checks while citing outdated protocols or hallucinating contraindications. This tutorial walks through practical evaluation patterns using LangChain tooling, grounded in recent advances and the realities of Singapore healthcare AI deployment.

This is for hospital AI teams, clinical informatics leads, and healthtech engineers building or procuring RAG systems for clinical use in Singapore and Asia.

Key takeaways

• Pairwise evaluation and trace mining are now standard LangChain patterns for iterating on RAG systems, but healthcare applications demand domain-specific judges and failure taxonomies [11, 15].
• Multi-turn misconception handling is critical for patient-facing or clinician-support LLMs; recent research shows current frameworks miss this failure mode entirely [7].
• GraphRAG architectures with two-stage extraction and typed consolidation reduce retrieval brittleness, but add complexity that Singapore hospitals must weigh against simpler vector RAG [8].
• Evaluation must align with NIST AI RMF risk categories and Singapore's PDPA/HSA requirements; technical metrics alone won't satisfy governance or clinical safety reviews [2].
• User-centered evaluation methods from digital health research offer templates for process evaluation and beta-testing that complement automated metrics [3].

Why standard RAG evaluation fails in healthcare

Most RAG evaluation tutorials focus on question-answering accuracy: did the system retrieve the right chunk, did the answer match a gold label? In clinical settings, this framing is insufficient.

First, clinical queries often embed misconceptions. A recent preprint introduces a benchmark for multi-turn medical conversations where patients ask questions with false assumptions—"Is my antibiotic safe with grapefruit juice?" when the patient isn't on an antibiotic but a statin [7]. Current RAG evaluation frameworks measure answer quality but not misconception detection and correction. For Singapore hospitals deploying patient-facing chatbots or clinical decision support, this is a critical gap.

Second, retrieval brittleness compounds in noisy knowledge graphs. The RAGU preprint demonstrates that single-pass entity extraction produces noisy graphs and fragile retrieval; two-stage typed extraction with consolidation improves robustness [8]. For hospitals with heterogeneous clinical data—ICD-10-SG codes, free-text discharge summaries, imaging reports—this architectural choice matters. But it also adds latency and complexity. Singapore public hospitals operating under tight IT budgets must evaluate whether the robustness gain justifies the engineering overhead.

Third, fluency illusions mask safety failures. We've written before about why fluency alone fails medical LLM evaluation. A RAG system can retrieve the correct guideline chunk, then hallucinate a contraindication in the generation step. Standard metrics like BLEU or ROUGE won't catch this. You need domain-specific judges—either clinician review or fine-tuned evaluator models—and you need to log retrieval provenance for every answer.

How LangChain's pairwise evaluation and trace mining work

LangChain's LangSmith platform now supports pairwise evaluation: comparing two system variants (e.g., different retrieval strategies, prompt templates, or LLM backbones) on the same query set, then using a judge model to pick the better response [11]. This is faster than absolute scoring and aligns with how clinicians think: "Which answer would I trust more?"

The workflow:

1. Define a test set of clinical queries with known ground truth or expert-reviewed answers.
2. Run both system variants and log traces (retrieval steps, LLM calls, final outputs).
3. Use a judge LLM (e.g., GPT-4, Claude, or a fine-tuned domain model) to compare responses pairwise.
4. Aggregate win rates and drill into failure cases.

LangChain also emphasizes trace mining: treating production logs as a data source to find failure modes, then fine-tuning cheaper judge models on those examples [15]. For Singapore hospitals, this means you can start with a frontier LLM as a judge, mine disagreements or edge cases, then fine-tune a smaller model (e.g., a domain-adapted Llama or Mistral) to run evals at lower cost. This is especially relevant given Singapore's push for local compute and data residency under PDPA.

A practical LangChain RAG evaluation setup for Singapore hospitals

Here's a minimal evaluation harness. This example uses LangSmith's pairwise API (conceptual; adapt to your LangChain version):

```python
from langsmith import Client
from langchain.evaluation import load_evaluator

Define test queries (clinical scenarios) test_queries = [ {"query": "What is the first-line treatment for community-acquired pneumonia in adults?", "context": "Singapore MOH CPG 2023"}, {"query": "Can I prescribe metformin to a patient with eGFR 35?", "context": "Renal dosing guidelines"}, ]

Run two RAG variants responses_a = [rag_system_a.run(q["query"]) for q in test_queries] responses_b = [rag_system_b.run(q["query"]) for q in test_queries]

Pairwise judge (using GPT-4 as evaluator) evaluator = load_evaluator("pairwise_string", llm="gpt-4")

for i, q in enumerate(test_queries):
result = evaluator.evaluate_string_pairs(
prediction=responses_a[i],
prediction_b=responses_b[i],
input=q["query"],
reference=q.get("gold_answer"), # optional
)
print(f"Query {i}: Winner = {result['value']}, Reasoning = {result['reasoning']}")
```

Production cautions:

• Judge model bias: GPT-4 may favor verbose or Western-centric answers. Fine-tune a judge on Singapore clinical guidelines and local practice patterns.
• Retrieval provenance: Log which chunks were retrieved and their source documents. This is essential for clinical audit trails and HSA SaMD documentation (see our HSA AI-SaMD exemption pathway guide).
• Data privacy: Do not send real patient data to external LLM APIs. Use de-identified test cases or synthetic data. For production evaluation, consider on-premises LLMs or Singapore-hosted inference (e.g., NVIDIA NIM, Azure Singapore regions).
• Human review: Automated evals are for iteration speed. Before clinical deployment, have domain experts review a stratified sample of outputs, especially edge cases and high-risk queries (e.g., drug interactions, contraindications).

Multi-turn misconception handling: the missing evaluation layer

The recent arXiv preprint on multi-turn medical misconceptions [7] highlights a gap: patients (and sometimes clinicians) ask questions with embedded false beliefs. A RAG system that simply answers the question may reinforce the misconception.

For Singapore hospitals deploying patient-facing chatbots or clinical decision support, add a misconception detection layer to your evaluation:

1. Curate test cases where the query contains a false assumption (e.g., "I'm taking penicillin for my viral cold—can I drink alcohol?").
2. Evaluate whether the system identifies the misconception (penicillin doesn't treat viral infections) before answering the alcohol question.
3. Score correction quality: Does the system explain the error clearly and suggest the right action (e.g., "Antibiotics like penicillin don't work for viral colds. If you were prescribed one, please check with your doctor.")?

This requires custom rubrics and likely clinician review. We've found it useful to adapt process evaluation methods from digital health research [3], where beta-testing and user interviews surface failure modes that automated metrics miss.

GraphRAG vs. vector RAG: when does the complexity pay off?

The RAGU preprint [8] demonstrates that two-stage GraphRAG—typed entity extraction, then consolidation into a knowledge graph—reduces retrieval brittleness compared to single-pass extraction or pure vector search. For Singapore hospitals, the tradeoff is:

GraphRAG advantages:
- Better handling of multi-hop reasoning (e.g., "What are the contraindications for Drug X in patients with Condition Y?").
- Explicit entity linking to ICD-10-SG, SNOMED-CT, or local formularies.
- Easier audit trails: you can inspect the graph structure and see why an entity was retrieved.

GraphRAG costs:
- Higher engineering complexity: entity extraction, schema design, graph maintenance.
- Latency: two-stage extraction and graph traversal add milliseconds to seconds.
- Harder to debug: graph construction errors propagate silently.

Our recommendation: start with vector RAG for most clinical Q&A use cases (discharge summaries, medication reconciliation, patient education). Move to GraphRAG only if you have:
- Multi-hop reasoning requirements (e.g., clinical pathways, drug-drug-condition interactions).
- Engineering capacity to maintain the graph pipeline.
- A clear evaluation showing that GraphRAG outperforms vector RAG on your test set.

For hospitals with limited AI engineering teams, the simpler architecture is often the safer bet. See our clinical AI services for deployment support.

Why this matters in Singapore and Asia

Singapore's healthcare AI landscape in 2026 is shaped by three forces:

1. Regulatory maturity: HSA's AI-SaMD framework and PDPA data protection rules demand documented evaluation and audit trails. A RAG system that can't explain its retrieval provenance won't pass clinical governance review.
2. Multilingual complexity: Singapore hospitals serve English, Mandarin, Malay, and Tamil speakers. RAG systems must handle code-switching and culturally specific health beliefs. Evaluation must include non-English test cases.
3. Resource constraints: Public hospitals operate under tight IT budgets. Evaluation frameworks that require expensive frontier LLMs for every test run aren't sustainable. Trace mining and fine-tuned judges [15] offer a path to cost-effective iteration.

Across Asia, we see similar patterns: high clinical AI ambition, but limited engineering capacity and strict data residency rules. LangChain's modular evaluation tools are useful, but they must be adapted to local regulatory and operational realities. The NIST AI Risk Management Framework [2] provides a helpful taxonomy (e.g., validity, reliability, safety, fairness) that maps well to Singapore's governance expectations.

What to do next

• Build a clinical test set: 50–100 queries covering common use cases, edge cases, and known failure modes. Include misconception scenarios and multilingual queries if relevant.
• Instrument your RAG pipeline: Log retrieval steps, chunk sources, LLM calls, and final outputs. Use LangSmith or an equivalent observability tool.
• Run pairwise evals when comparing system variants (e.g., different embedding models, retrieval strategies, or LLM backbones). Use a judge model, but validate with clinician review on a sample.
• Fine-tune a domain judge: Start with GPT-4 or Claude as a judge, mine disagreements, then fine-tune a smaller model on Singapore clinical guidelines and local practice patterns.
• Align evaluation with governance: Map your metrics to NIST AI RMF categories and HSA SaMD requirements. Document retrieval provenance and failure modes for clinical audit. See our PDPA and HSA compliance checklist.
• Pilot with a low-risk use case: Start with patient education or administrative Q&A, not high-stakes clinical decision support. Iterate on evaluation before scaling.

If you're building or procuring a RAG system for clinical use, start a project with us to design an evaluation framework that satisfies both technical and governance requirements.

FAQ

What's the minimum test set size for clinical RAG evaluation?

Start with 50–100 queries covering your core use cases, edge cases, and known failure modes. Stratify by clinical domain (e.g., medication queries, discharge instructions, lab interpretation) and risk level. Add misconception scenarios and multilingual queries if relevant. This is enough to compare system variants and catch major failure modes. Scale to 500+ queries for production validation.

Should I use GPT-4 or a fine-tuned model as a judge?

Start with GPT-4 or Claude for speed and generality. Once you've run 100+ evaluations, mine disagreements (cases where the judge's score doesn't match clinician review) and fine-tune a smaller model (e.g., Llama 3 8B, Mistral 7B) on Singapore clinical guidelines and local practice patterns. This reduces cost and keeps evaluation data on-premises, which matters for PDPA compliance.

How do I evaluate retrieval quality separately from generation quality?

Log the retrieved chunks for each query. Evaluate retrieval with metrics like precision@k (what fraction of retrieved chunks are relevant?) and recall (did the system retrieve the key guideline or evidence?). Then evaluate generation separately: given the retrieved chunks, is the answer accurate, complete, and safe? This separation helps you diagnose whether failures are due to bad retrieval (wrong chunks) or bad generation (hallucination, misinterpretation).

What if my RAG system needs to handle multi-turn conversations?

Add conversation history to your test cases. Evaluate whether the system maintains context across turns, detects when a user's question contradicts earlier statements, and corrects misconceptions. The recent multi-turn misconception benchmark [7] is a useful reference. For production systems, log full conversation traces and sample high-risk multi-turn exchanges for clinician review.

Sources

[1] Multi-dimensional evaluation of user-operated audible contrast sensitivity tests towards efficient hearing healthcare services. PLOS Digital Health, 2026-07-13. https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0000975

[2] NIST AI Risk Management Framework. NIST. https://www.nist.gov/itl/ai-risk-management-framework

[3] Designing user-centered evaluations: Leveraging beta-testing results to develop process evaluation interview questions for the AMPLIFY program. PLOS Digital Health, 2026-07-07. https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001477

[4] Evaluating Large Language Models on Misconceptions in Multi-Turn Medical Conversations. arXiv preprint, 2026-07-14. https://arxiv.org/abs/2607.12884v1

[5] RAGU: A Multi-Step GraphRAG Engine with a Compact Domain-Adapted LLM. arXiv preprint, 2026-07-13. https://arxiv.org/abs/2607.11683v1

[6] Pairwise Evaluations with LangSmith. LangChain Blog, 2026-06-30. https://www.langchain.com/blog/pairwise-evaluations-with-langsmith

[7] Improving Agents is a Data Mining Problem. LangChain Blog, 2026-07-08. https://www.langchain.com/blog/improving-agents-is-a-data-mining-problem